RxDoctor Payments Data

Anthony Infantolino, MD

Gastroenterology · Mount Laurel, NJNPI 1164481032

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,042 of the $31,644 with a category attached, or 60.2%. Medtronic accounts for 60.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $9,130 and has fallen 80.5% since, to $1,782 in 2025. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,644in general payments, 2019–2025

Across 160 payments — averaging $197.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$19K
  • Covidien LP$9K
  • Fujifilm Healthcare Americas Corporation$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Boston Scientific$174
  • Bristol Myers Squibb$135
  • plus $915 from 17 others
$31,381in research payments, 2019–2025

Across 4 payments — averaging $7845.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pentax Of America, Inc.$18K
  • Lucid Diagnostics Inc.$13K

What the payments were for

  • Consulting fees$4,26813%
  • Speaking & faculty fees$19,04260%
  • Travel & lodging$3,96513%
  • Food & beverage$4,36914%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,644 in reported general payments places this provider in the 95th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey

Medicare billing

Part B allowed, 2024
$83,036
Medicare patients
305
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate36$8,680
Dexlansoprazole DrDexlansoprazole13$6,297
Omeprazole173$3,522
Pantoprazole Sodium77$1,454
Lansoprazole20$1,288
Esomeprazole Magnesium16$1,048
Famotidine48$545
Lidocaine Hcl ViscousLidocaine Hcl29$395

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Mount Laurel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →